Skip to main content
. 2021 Jun 1;10(6):892. doi: 10.3390/antiox10060892

Figure 7.

Figure 7

The graphical representation of the neuroprotective mechanism of estradiol against glutamate-induced neurodegeneration in developing rat brain. Exogenous glutamate (single subcutaneous injection of 10 mg/kg) treatment increased brain oxidative stress associated with the dysregulated MAP kinase pathway mediated neuroinflammation, synapse loss and neurodegeneration in postnatal 7-day rat brain. Co-administration of 17β-estradiol with glutamate alleviated glutamate-induced neurodegeneration in the developing rats.